These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 2635255

  • 21. The effects of ICI 118,587 and atenolol on the responses to exercise and on breathlessness in healthy subjects.
    O'Neill PA, Morton PB, Sharman P, Marlow HF, Stark RD.
    Br J Clin Pharmacol; 1984 Jan; 17(1):37-41. PubMed ID: 6229263
    [Abstract] [Full Text] [Related]

  • 22. Dietary nitrate reduces maximal oxygen consumption while maintaining work performance in maximal exercise.
    Larsen FJ, Weitzberg E, Lundberg JO, Ekblom B.
    Free Radic Biol Med; 2010 Jan 15; 48(2):342-7. PubMed ID: 19913611
    [Abstract] [Full Text] [Related]

  • 23. Diltiazem versus propranolol in essential hypertension: responses of rest and exercise blood pressure and effects on exercise capacity.
    Szlachcic J, Hirsch AT, Tubau JF, Vollmer C, Henderson S, Massie BM.
    Am J Cardiol; 1987 Feb 15; 59(5):393-9. PubMed ID: 3812308
    [Abstract] [Full Text] [Related]

  • 24. Modification of cellular immune functions in humans by endurance exercise training during beta-adrenergic blockade with atenolol or propranolol.
    Watson RR, Moriguchi S, Jackson JC, Werner L, Wilmore JH, Freund BJ.
    Med Sci Sports Exerc; 1986 Feb 15; 18(1):95-100. PubMed ID: 3485757
    [Abstract] [Full Text] [Related]

  • 25. Effect of dual beta-blockade and calcium antagonism on endurance performance.
    Gordon NF, van Rensburg JP, van den Heever DP, Kalliatakis NB, Myburgh DP.
    Med Sci Sports Exerc; 1987 Feb 15; 19(1):1-6. PubMed ID: 2881183
    [Abstract] [Full Text] [Related]

  • 26. Pharmacodynamics of racemic and S(-)-atenolol in humans.
    McCoy RA, Clifton GD, Clementi WA, Smith MD, Garvey TQ, Wermeling DP, Schwartz SE.
    J Clin Pharmacol; 1994 Aug 15; 34(8):816-22. PubMed ID: 7962669
    [Abstract] [Full Text] [Related]

  • 27. Effects of cardioselective and nonselective beta-adrenergic blockade on the performance of highly trained runners.
    Anderson RL, Wilmore JH, Joyner MJ, Freund BJ, Hartzell AA, Todd CA, Ewy GA.
    Am J Cardiol; 1985 Apr 26; 55(10):149D-154D. PubMed ID: 3993547
    [Abstract] [Full Text] [Related]

  • 28. [The efficacy of slow-release diltiazem in the treatment of stable angina of effort: a comparison between diltiazem and placebo].
    Vizza CD, Sciomer S, Guagnozzi G, Cifarelli MT, Pastore LR, Dagianti A, Fedele F, Dagianti A.
    Cardiologia; 1993 May 26; 38(5):311-5. PubMed ID: 8402740
    [Abstract] [Full Text] [Related]

  • 29. Exercise capacity, energy metabolism, and beta-adrenoceptor blockade. Comparison between a beta 1-selective and a non-selective beta blocker.
    Verstappen FT, van Baak MA.
    Eur J Appl Physiol Occup Physiol; 1987 May 26; 56(6):712-8. PubMed ID: 2890520
    [Abstract] [Full Text] [Related]

  • 30. Effect of atenolol or prazosin on maximal exercise performance in hypertensive joggers.
    Thompson PD, Cullinane EM, Nugent AM, Sady MA, Sady SP.
    Am J Med; 1989 Jan 23; 86(1B):104-9. PubMed ID: 2913765
    [Abstract] [Full Text] [Related]

  • 31. Exercise training during long-term beta-blockade treatment in healthy subjects.
    Savin WM, Gordon EP, Kaplan SM, Hewitt BF, Harrison DC, Haskell WL.
    Am J Cardiol; 1985 Apr 26; 55(10):101D-109D. PubMed ID: 3993543
    [Abstract] [Full Text] [Related]

  • 32. Effect of amino acid mixture intake on physiological responses and rating of perceived exertion during cycling exercise.
    Demura S, Nagasawa Y, Kitabayashi T, Matsuzawa J.
    Percept Mot Skills; 2003 Jun 26; 96(3 Pt 1):883-95. PubMed ID: 12831267
    [Abstract] [Full Text] [Related]

  • 33. [Comparative evaluation using an ergometric test of the efficacy of the 3 major calcium antagonists on exertion stable angina].
    Papa M, Acanfora D, Artiaco D, Santangelo L, Covelluzzi F, De Rosa ML, Cicatiello M, De Caprio L, Rengo F.
    G Ital Cardiol; 1987 Apr 26; 17(4):344-50. PubMed ID: 3653591
    [Abstract] [Full Text] [Related]

  • 34. Effect of acute calcium slow-channel antagonism on the cardiorespiratory response to graded exercise testing.
    Gordon NF, van Rensburg JP, Kawalsky DL, Russell HM, Celliers CP, Myburgh DP.
    Int J Sports Med; 1986 Oct 26; 7(5):254-8. PubMed ID: 3793333
    [Abstract] [Full Text] [Related]

  • 35. Exercise performance during captopril and atenolol treatment in hypertensive patients.
    Van Baak MA, Koene FM, Verstappen FT, Tan ES.
    Br J Clin Pharmacol; 1991 Dec 26; 32(6):723-8. PubMed ID: 1768565
    [Abstract] [Full Text] [Related]

  • 36. [Effect of atenolol and nitroglycerin ointment on exertion tolerance in coronary disease].
    Koenig W, Diehm C.
    Dtsch Med Wochenschr; 1983 Nov 25; 108(47):1798-803. PubMed ID: 6416805
    [Abstract] [Full Text] [Related]

  • 37. Effects of verapamil and atenolol on exercise tolerance in 5,000 m cross-country running: a double-blind cross-over study in normal humans.
    Herbertsson P, Fagher B.
    J Cardiovasc Pharmacol; 1990 Jul 25; 16(1):23-7. PubMed ID: 1696662
    [Abstract] [Full Text] [Related]

  • 38. Randomised, double-blind, three-way cross-over study of dilevalol 200 and 400 mg and atenolol 100 mg once-daily in patients with chronic stable angina pectoris.
    Bowles MJ, Smith L, Glover DR.
    J Hum Hypertens; 1990 Jun 25; 4 Suppl 2():85-90. PubMed ID: 2196372
    [Abstract] [Full Text] [Related]

  • 39. [Effect of calcium antagonists on physical fitness and metabolism].
    Kindermann W, Schmitt W, Stengele E.
    Dtsch Med Wochenschr; 1985 Oct 25; 110(43):1657-61. PubMed ID: 3899571
    [Abstract] [Full Text] [Related]

  • 40. Comparison of antihypertensive activity of atenolol and methyldopa at rest and during exercise.
    Magnani B, Ambrosioni E, Costa FV, Malini PL, Magelli C.
    Int J Clin Pharmacol Ther Toxicol; 1981 Oct 25; 19(10):440-4. PubMed ID: 7287240
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.